JOHN VU: Open Payments
NPI 1457458085 · MCDONOUGH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 7 payments from 5 companies in 2025. Trend: 2023 $160 · 2024 $429 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 3 | $240 |
| Corcept Therapeutics | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: DAXXIFY, Korlym, FARXIGA, Ozempic, JARDIANCE.
Industry payments across GA — which companies pay providers there.
